Professor Dame Pam Shaw will from September 2019 be stepping down from her role as Vice-President for the Faculty of Medicine, Dentistry and Health to focus on her role as Director of the University’s new Institute for Neuroscience, as well as continuing her clinical work in Neurology.
Pam has provided fantastic leadership to the Faculty since 2016 and through her ‘Be the Best We Can Be’ strategy she has raised the ambition and delivered improvements across Medicine, Dentistry and Health. Under her direction there has been a significant increase in research grant capture and strong performance across learning and teaching. She has also played a major part in attracting a number of leading academics to Sheffield who are inspired by the Faculty’s vision.
Pam has been instrumental in supporting plans to establish a revolutionary MRI-PET scanner in Sheffield, which will transform our understanding of serious conditions such as cancer, dementia, heart and lung diseases, MND, Parkinson’s and stroke. This has included leading a huge fundraising effort to raise £2 million as part of the successful Sheffield Scanner campaign.
Pam said: “It has been a great honour and privilege to be Vice-President and Head of the Faculty of Medicine, Dentistry and Health over the past three years. I so much appreciate my colleagues in the Faculty getting behind the ‘Being the Best we can Be’ endeavour, which has encouraged us to uplift our position on many fronts in research and in learning and teaching. The support and wise advice of Professor Sir Keith Burnett and our new President and Vice-Chancellor Professor Koen Lamberts and members of the University Executive Board have also been hugely valuable.
“I believe that now is the right time to return to my roots in Neurology and Neuroscience, in order to help steer the success of the Institute for Neuroscience, which is such an exciting initiative for our University. So with a huge thank you to colleagues in the Faculty and the wider University for all of their loyalty and support, my very best wishes for the future. I expect to observe with pride continuing positive developments and great achievements in coming years, building on the solid foundation we have created together.”
We would like to thank Pam for her support and contribution to the Insigneo Institute through her invaluable input as a member of our Steering Committee. We wish her the best in her new ventures which Insigneo supports through continued collaborative research.
Professor Claudia Mazzà, Interim Executive Director of the Insigneo Institute for in silico Medicine, said, “I have always had great admiration for Pam Shaw as a role model for female academics and for her remarkable clinical and research work at SITRaN and the NIHR Sheffield Biomedical Research Centre. I am looking forward to the forthcoming cross-institute collaborations”.